Cargando…
CD59-Regulated Ras Compartmentalization Orchestrates Antitumor T-cell Immunity
T cell–mediated immunotherapy represents a promising strategy for cancer treatment; however, it has achieved satisfactory clinical responses in only a limited population. Thus, a broader view of the T-cell immune response is required. The Ras/MAPK pathway operates in many important signaling cascade...
Autores principales: | Li, Luying, Ding, Peipei, Lv, Xinyue, Xie, Suhong, Li, Ling, Chen, Jianfeng, Zhou, Danlei, Wang, Xiaochao, Wang, Qi, Zhang, Wei, Xu, Yanqing, Lu, Renquan, Hu, Weiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716252/ https://www.ncbi.nlm.nih.gov/pubmed/36206575 http://dx.doi.org/10.1158/2326-6066.CIR-21-1072 |
Ejemplares similares
-
CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair
por: Zhou, Yuzhen, et al.
Publicado: (2018) -
Midostaurin potentiates rituximab antitumor activity in Burkitt’s lymphoma by inducing apoptosis
por: Ge, Xiaowen, et al.
Publicado: (2018) -
Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer
por: Wang, Xiaochao, et al.
Publicado: (2023) -
Increased α-HB links colorectal cancer and diabetes by potentiating NF-κB signaling
por: Lv, Xinyue, et al.
Publicado: (2023) -
Compartmentalized Ras signaling in lymphocytes
por: Philips, MR
Publicado: (2009)